LARGE FAMILY FOR LARGE ACHIEVEMENTS
We develop modern prevention, diagnostics and therapy products for health preservation and improved quality of life.
Press centre
NOTICE/RECONVENING REGULAR ANNUAL ASSEMBLY
NOTICE ON RECONVENING THE REGULAR ANNUAL SHAREHOLDERS ASSEMBLY OF BOSNALIJEK JSC
In accordance with provisions of Article 233 Paragraph 2 to 4 of the current Law on Business Companies and Article 55 Paragraph 2 and 3 of the current Statute of Bosnalijek JSC and Decision No 3132/24 of 20 June 2024, the Supervisory Board of the company Bosnalijek JSC publishes:
MORE
PRESS CENTAR / NEWS
Danish journalists were convinced of the top quality of Bosnalijek
The largest domestic pharmaceutical company, Bosnalijek hosted a group of 16 journalists from Denmark, employees of the magazine "Borzen". Borzen journalists decided to visit Bosnalijek as a part of their trip to Bosnia and Herzegovina.
In detail
PRESS CENTAR / NEWS
Cooperation Agreement Signed between Bosnalijek and Abdi Ibrahim – Bosnalijek’s Products About to E ...
Bosnalijek and Abdi Ibrahim, the largest pharmaceutical companies from Bosnia and Herzegovina and the Republic of Turkey, announced a signing of cooperation agreement in Sarajevo for the placement of Bosnalijek products on the Turkish market.
In detail
Useful Resources
juli 16. 2024 |
SASE |
BSNLR - Bosnalijek d.d. Sarajevo: 12,47 3,89%